Brief Communications in 2020 | Nature Medicine
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera | Nature Medicine
Countries Primarily Using CoronaVac Vaccines Should Consider mRNA Vaccine Boosters to face Omicron
Antibody responses to SARS-CoV-2 in patients with COVID-19
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
Pilot study of responsive nucleus accumbens deep brain stimulation for loss-of-control eating | Nature Medicine
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant | Nature Medicine
Temporal dynamics in viral shedding and transmissibility of COVID-19 | Nature Medicine
Brief Communications in 2021 | Nature Medicine
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 | Nature Medicine
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Brief Communications in 2021 | Nature Medicine
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Brief Communications in 2021 | Nature Medicine
Nature Medicine
Real-time tracking of self-reported symptoms to predict potential COVID-19 | Nature Medicine
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine
Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination | Nature Medicine
Brief Communications | Nature Medicine
Nature Medicine
目次 | Nature Medicine | Nature Portfolio
A serological assay to detect SARS-CoV-2 seroconversion in humans
